Press Releases

All Releases
View Summary Myriad Genetics to Present at the Citi 2010 Global Health Care Conference
May 13, 2010
PDF 13.2 KB Add to Briefcase
View Summary Myriad Genetics Reports Financial Results for Fiscal 2010 Third Quarter
May 4, 2010
PDF 21.6 KB Add to Briefcase
View Summary Myriad Announces Stock Repurchase Program
May 4, 2010
PDF 14.2 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Ninth Annual JMP Securities Research Conference
Apr 28, 2010
PDF 12.9 KB Add to Briefcase
View Summary Myriad Genetics Announces New, Convenient OnDose(TM) Sampling Kit
Apr 27, 2010
PDF 15.9 KB Add to Briefcase
View Summary Myriad Study Shows PTEN Gene is Useful in Predicting Prostate Cancer Recurrence
Apr 19, 2010
PDF 15.4 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2010 Third Quarter Financial Results On May 4
Apr 13, 2010
PDF 12.2 KB Add to Briefcase
View Summary Federal District Court Rules Isolated DNA Claims are Not Patentable
Mar 30, 2010
PDF 15.5 KB Add to Briefcase
View Summary Novel Gene Expression Test, PROLARIS(TM), Accurately Predicts Prostate Cancer Recurrence
Mar 8, 2010
PDF 16.1 KB Add to Briefcase
View Summary Myriad Genetics Launches PROLARIS(TM): First Diagnostic Test to Predict Prostate Cancer Recurrence
Mar 2, 2010
PDF 16.2 KB Add to Briefcase
View Summary New Study Finds 41% of Patients at Community Oncology Practices Were at Risk for Hereditary Breast/Ovarian Cancer
Feb 25, 2010
PDF 15.7 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Cowen and Company 30th Annual Health Care Conference
Feb 23, 2010
PDF 13.2 KB Add to Briefcase
View Summary Myriad Genetics to Host Investor Day in New York
Feb 17, 2010
PDF 15.0 KB Add to Briefcase
View Summary Myriad Genetics to Present at the RBC Capital Markets' Healthcare Conference
Feb 16, 2010
PDF 13.2 KB Add to Briefcase
View Summary Myriad Genetics Reports Financial Results for Fiscal 2010 Second Quarter
Feb 2, 2010
PDF 22.0 KB Add to Briefcase
View Summary Myriad Study Reveals Patients Receive Suboptimal Dosing With Chemotherapy Regimens of FOLFOX6 and FOLFOX6 Plus Avastin
Jan 25, 2010
PDF 16.8 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Seventh Annual Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO)
Jan 14, 2010
PDF 13.0 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2010 Second Quarter Financial Results on February 2
Jan 12, 2010
PDF 12.2 KB Add to Briefcase
View Summary Myriad Genetics Partners With Mammography Reporting Systems to Increase Identification of High Risk Breast Cancer Patients
Jan 6, 2010
PDF 16.4 KB Add to Briefcase
View Summary Myriad Genetics to Present at the 28th Annual J.P. Morgan Healthcare Conference
Dec 17, 2009
PDF 12.8 KB Add to Briefcase
Showing 161-180 of 307 Page: 1 ... 5 6 7 8 9 10 11 12 13 ... 16  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
37.56
Change:
- 0.07
Open:
37.71
Previous Close:
37.63
Day High:
38.12
Day Low:
37.18
52 Week High:
42.50
52 Week Low:
20.02
Volume:
182,100
12:39 PM ET on Jul 24, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com